A research team led by Prof. Jiang Yanyi from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...

Mohs surgery significantly improved recurrence, metastasis, and mortality rates in patients with primary high-stage cutaneous ...

The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

Purple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...

Utrecht, The Netherlands Thursday, February 20, 2025, 15:00 Hrs [IST] ...

The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising ...

Researchers evaluated demographic characteristics associated with survival trends in patients with squamous cell carcinoma of the upper esophagus.

The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company ...